However, the Kaplan–Meier test and the subsequent log-rank comparison test establish that there was no correlation between the grade of UBE2O immunohistochemical staining and prostate cancers’ biochemical recurrence, clinical recurrence, or OS. The gene discussed is UBE2O; the disease is prostate cancer.